NousCom receives $49M to trial off-the-shelf cancer vaccine
Cancer vaccine startup NousCom has raised €42 million ($49…
AstraZeneca bolts Incyte’s IDO1 immunomodulator to its lung cancer plans
AstraZeneca has enlisted the aid of Incyte to try to boost its…